IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 225 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $101,854 | -45.9% | 12,700 | 0.0% | 0.00% | -40.0% |
| Q1 2024 | $188,214 | +82.3% | 12,700 | 0.0% | 0.01% | +66.7% |
| Q4 2023 | $103,251 | -72.1% | 12,700 | +8.5% | 0.00% | -78.6% |
| Q1 2021 | $370,000 | -31.9% | 11,700 | 0.0% | 0.01% | -44.0% |
| Q4 2020 | $543,000 | -6.9% | 11,700 | -33.9% | 0.02% | -16.7% |
| Q3 2020 | $583,000 | +15.4% | 17,700 | -3.8% | 0.03% | +7.1% |
| Q2 2020 | $505,000 | -74.7% | 18,400 | -72.4% | 0.03% | -80.3% |
| Q1 2020 | $1,994,000 | -58.4% | 66,600 | -77.0% | 0.14% | -47.4% |
| Q4 2019 | $4,792,000 | +52.7% | 289,500 | +67.9% | 0.27% | +42.1% |
| Q3 2019 | $3,138,000 | – | 172,400 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |